Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population Xue-hong LiangLiucheng RongYongjun Fang Original Article Open access 09 December 2016 Pages: 339 - 344
GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling Corinna KochBardia SamarehKarl Welte Original Article 14 December 2016 Pages: 345 - 353
Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012 Luiz Claudio Santos ThulerMaria S. Pombo-de-Oliveira Original Article 18 October 2016 Pages: 355 - 362
Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant? Etienne PaubelleSophie Ducastelle-LeprêtreXavier Thomas Original Article 23 December 2016 Pages: 363 - 371
Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013 Ja Min ByunYoung Jin KimTae Sung Park Original Article 27 December 2016 Pages: 373 - 381
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort Jean-Christophe IanottoAurélie ChauveauAurélien Delluc Original Article 20 October 2016 Pages: 383 - 386
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN Massimo BrecciaAlessandro AndrianiRoberto Latagliata Original Article 26 November 2016 Pages: 387 - 391
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations Danijela LekovicMirjana GoticVladan P. Cokic Original Article 06 December 2016 Pages: 393 - 404
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy Ivan DlouhyMiguel Á. TorrenteArmando López-Guillermo Original Article 29 December 2016 Pages: 405 - 410
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment Hideaki KitaharaDai MaruyamaKensei Tobinai Original Article 07 December 2016 Pages: 411 - 420
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients Stefanie GilliUrban NovakThomas Pabst Original Article 24 December 2016 Pages: 421 - 429
Bortezomib-containing regimens (BCR) for the treatment of non-transplant eligible multiple myeloma Victor H Jimenez-ZepedaPeter DugganNizar J Bahlis Original Article 10 January 2017 Pages: 431 - 439
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic Ariana BerensonSuzie VardanyanJames R. Berenson Original Article 02 December 2016 Pages: 441 - 448
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib Ariana BerensonSuzie VardanyanJames R. Berenson Original Article 08 December 2016 Pages: 449 - 459
Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone Noam BenyaminiIrit AviviTami Katz Original Article 24 December 2016 Pages: 461 - 467
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8 Takaaki KonumaTadakazu KondoAdult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Original Article 06 January 2017 Pages: 469 - 478
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML Udo HoltickMarco HerlingJens M. Chemnitz Original Article 01 December 2016 Pages: 479 - 487
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause Johanna GebhartSylvia KepaIngrid Pabinger Original Article Open access 26 December 2016 Pages: 489 - 495
Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome Fatemeh BehniaSaeed ElojeimyDavid C. Fajgenbaum Letter to the Editor 16 November 2016 Pages: 497 - 500
Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy Zimu GongLan ZhengShimin Hu Letter to the Editor 03 December 2016 Pages: 501 - 504
Evidence for a role of decitabine in the treatment of myeloid sarcoma Max GornicecAlbert WölflerArmin Zebisch Letter to the Editor 06 November 2016 Pages: 505 - 506
Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center Karla Javier GonzálezSebastian Ortiz ZuluagaAntonio Cerveró Martí Letter to the Editor 15 December 2016 Pages: 507 - 508
Cold agglutinin disease complicated by acrocyanosis and necrosis Gareth P. GregoryAnn FarrellSusan Brown Letter to the Editor 03 January 2017 Pages: 509 - 510
Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case Khaoula Ben YounesRaoudha DoghriFatma Ben Aissa-Fennira Letter to the Editor 20 October 2016 Pages: 511 - 512
Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide Yok-Lam Kwong Letter to the Editor 12 November 2016 Pages: 513 - 515
Intravascular lymphoma: look through the small vessels Concepción Prats-MartínEmilio Franco-MacíasJosé A. Pérez-Simón Letter to the Editor 12 November 2016 Pages: 517 - 519
Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD Sainath BhethanabhotlaSameer Bakhshi Letter to the Editor 18 November 2016 Pages: 521 - 522
Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry Edurne SarrateMarc SorigueJordi Juncà Letter to the Editor 08 December 2016 Pages: 523 - 524
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence Shin Yeu OngYun Ann ChinHeng Joo Ng Letter to the Editor 07 November 2016 Pages: 525 - 527
Reversion of serum VZV-IgG antibody preceding disseminated visceral varicella zoster after hematopoietic stem cell transplantation Sayaka ArakawaHidenori KageTakahide Nagase Letter to the Editor 14 November 2016 Pages: 529 - 530
